Filter posts

BIO IPCC Spring Conference Program Announced

BIO’s 2015 IP Counsels Committee Spring Conference & Meeting will be held April 15-17 in …

BIO and Universities Caution Against Innovation Act, Emphasize the Need for Patent Protection

In light of House Judiciary Committee Chairman Bob Goodlatte’s (R-VA) re-introduction of the Innovation Act, …

BIO Deputy General Counsel Remarks on Revised Eligibility Guidance

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property recently spoke at the U.S. Patent …

USPTO Issues New Myriad Guidance

On Tuesday, December 16 the United States Patent and Trademark Office issued a revised guidance …

Patently Biotech’s Top Articles of 2014

It’s been a whirlwind year for IP. From international trade negotiations, to revised PTO guidelines …

BIO Coalition Submits Patent Reform Letter to Congress

BIO, alongside a coalition of patent holders and inventors, submitted a letter to the chairmen …

Now What is Patentable?

On Tuesday of the Pacific Rim Summit, experts from Knobbe Martens, BIO, and Synthetic Genomics explored the …

Indian Patents Ensure Wide Access to Drugs, Without Raising Prices

Two recent studies on Indian drugs have shown that patent protection does not dramatically increase …

Patent Trolls and Nigerian Scammers

What do patent trolls and Nigerian princes have in common? Two things come to mind. …

New Report Emphasizes the Role of Patent Protection in the Global Diffusion of New Drugs

A new report from the National Bureau of Economic Research (NBER) has determined that strong …